For Business Use Only. Does Not Ship to Residential Addresses. For use inside an Analyzer, Sold Separately.

Thermo Kit EtG Rgt DRI CJF

https://www.blockscientific.com/web/image/product.template/97754/image_1920?unique=1400e5e

443.45 443.45 USD 443.45

443.45

    This combination does not exist.

    In Stock

    Product code: T-10016154

    MPN: 10016154

    Manufacturer: Thermo Scientific

    Shipping Weight: 2.00lbs (0.91kg)

    WHY CHOOSE BLOCK SCIENTIFIC?
    See why in 2 mins.

    Thermo Kit EtG Rgt DRI CJF

    Specifications

    • Brand: DRI®
    • Manufacturer: Ortho Clinical Diagnostics
    • Country of Origin: United States
    • Application: Reagent
    • For Use With: For Clinical Chemistry Analyzers
    • Form: Liquid
    • Sample Type: Urine Sample
    • Storage Requirements: Requires Refrigeration
    • Test Name: Ethyl Glucuronide (EtG)
    • Test Type: Drugs of Abuse
    • Volume: 3x18 mL


    Intended Use

    The Thermo ScientificTM DRI Ethyl Glucuronide Enzyme Immunoassay is intended for the qualitative and semi-quantitative determination of Ethyl Glucuronide in human urine at cutoffs of 500 ng/mL and 1000 ng/mL.


    Summary and Explanation of the Test

    Ethyl Glucuronide (EtG) is a direct metabolite of ethanol, which is formed by enzymatic conjugation of ethanol with glucuronic acid. Alcohol in urine is normally detected for only a few hours, where as EtG can be detected up to several days even after complete elimination of alcohol from the body. Currently EtG is monitored by GC/MS and LC/MS/MS.

    The DRI® Ethyl Glucuronide Assay is supplied as a liquid ready-to-use homogeneous enzyme immunoassay. The assay uses specifi c antibodies that can detect Ethyl Glucuronide without any significant cross-reactivity to other glucuronide compounds. The assay is based on competition between a drug labeled with glucose-6-phosphate dehydrogenase (G6PDH), and free drug from the urine sample for a fi xed amount of specifi c antibody binding sites. In the absence of free drug from the sample, the specifi c antibody binds the drug labeled with G6PDH and causes a decrease in enzyme activity. This phenomenon creates a direct relationship between the drug concentration in urine and enzyme activity. Active enzyme converts NAD to NADH resulting in an absorbance change that can be measured spectrophotometrically at 340 nm.